Inoue, US
Akihide Inoue, Los Gatos, CA US
Patent application number | Description | Published |
---|---|---|
20150347200 | SHARING EXTENSION POINTS TO ALLOW AN APPLICATION TO SHARE CONTENT VIA A SHARING EXTENSION - A sharing extension point receives a request from a host application for sharing content, the sharing extension point being one of the extension points of an extension framework of an operating system, each corresponding to a common interface to extend a predefined functionality of one application to another application. In response, a sharing extension capable of providing content sharing services is launched. Data representing a share sheet created by the sharing extension is injected into a content viewer within the host application as a share sheet clone, where the share sheet clone has a reduced resolution image of the content displayed therein. In response to receiving a commit command for sharing, the actual content is retrieved from the host application and the retrieved content is transmitted to the sharing extension to enable the sharing extension to post the share sheet on a sharing platform. | 12-03-2015 |
Heather Inoue, Oak Park, CA US
Patent application number | Description | Published |
---|---|---|
20090155274 | HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 06-18-2009 |
20100034818 | Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 02-11-2010 |
20110040076 | Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 02-17-2011 |
20110091476 | Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 04-21-2011 |
Hiromi Inoue, Sacramento, CA US
Patent application number | Description | Published |
---|---|---|
20150132408 | SORAFENIB DERIVATIVES AS P21 INHIBITORS - The present invention provides sorafenib analogs for use in a method of treating a disease mediated by p21, said method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula I. The present invention also provides methods of inhibiting p21 in a cell comprising contacting the cell with an effective amount of a compound of formula I. | 05-14-2015 |
Junichi Inoue, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110186065 | Frontal Hairpiece - A frontal hairpiece for providing a naturally-appearing augmented frontal hairline when applied to the wearer. A frontal foundation has a forward edge, a rearward edge, a first end and a second end. The frontal foundation is thin, flexible and made from a net-like construction which substantially blends with the skin color of the wearer. The forward edge traces a tortuous pathway from approximately the first end to approximately the second end. Embodiments may include an elastic band portion connected to the frontal foundation, with first and second rear strap portions disposed therebetween. Hair is attached to the frontal foundation in a first density pattern which mimics a natural transition of a wearer's forehead into a frontal hairline. The first density pattern of some embodiments may be characterized by a greater density of hair strands applied proximate the rearward edge of the frontal foundation compared to the density of hair strands applied proximate the forward edge. | 08-04-2011 |
Kanji Inoue US
Patent application number | Description | Published |
---|---|---|
20140236220 | DEVICE FOR CAPTURING DEBRIS IN BLOOD VESSELS - Provided is a device for capturing debris in blood vessels, which enables a filter member to be smoothly recovered, and has a simple structure leading to an easy operation. For this purpose, provided is an elastic steel wire that, in a folded state, extends in a direction toward a base of a slide tube from a fore end part of a holding part in a ringlike elastic wire rod along an outer side of the slide tube. | 08-21-2014 |
Keiichi Inoue, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110189308 | METHODS TO TREAT NEURODEGENERATIVE CONDITIONS OR DISEASES BY TARGETING COMPONENTS OF A PTEN SIGNALING PATHWAY - The disclosure provides that components of a PTEN cell signaling pathway may be utilized as therapeutic targets for treating, preventing, slowing the progression of or delaying the onset of a neurodegenerative disease or disorder. Such components that may be targeted include, phosphatase and tensin homologue (PTEN), glycogen synthase kinase 3 beta (GSK3β), and AKT. The subject matter disclosed herein relates to the therapeutic use of inhibitors of PTEN, inhibitors of GSK3β, or activators of AKT to treat a neurodegenerative disease or disorder in a subject. Compounds are disclosed which may be used in the methods provided. | 08-04-2011 |
Kosuke Inoue, Corona Del Mar, CA US
Patent application number | Description | Published |
---|---|---|
20090241960 | DUAL HIGH AND LOW PRESSURE BREATHING SYSTEM - A breathing system allows a single valve and corresponding control system to utilize either high or low pressure gas input and control the delivery of gas to a patient in a manner independent of the gas pressure level. Some such systems include a blower that provides gas with low pressure, a high pressure inlet port, a force balance valve or similar that will regulate the high pressure to work in the low pressure system, and a proportional valve assembly with a unitary control system that will allow for efficient ventilation operations regardless of gas source. Some such systems are capable of seamless transition from low to high pressure and from high to low pressure gas sources, as well as independent operation while either source serves as an input. | 10-01-2009 |
Makoto Inoue, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20120177632 | METHODS OF OPTIMIZING DISEASE TREATMENT - Provided are methods for optimizing treatment of an autoimmune disease in a subject, methods for identifying and/or selecting a compound as a therapeutic for an autoimmune disease, methods of identifying a patient that is responsive to IFN-β therapy, and methods for identifying an agent that inhibits NLRP | 07-12-2012 |
Masaya Inoue US
Patent application number | Description | Published |
---|---|---|
20150249372 | ELECTRIC MACHINE - In the electric machine according to the present invention, conductor wires are housed inside slots so as to be arranged into multiple layers in one column so as to contact each other in a slot depth direction in each column such that a longitudinal direction of a long side of an oblong cross section of a conductor portion faces in the slot depth direction, and a thickness of a portion of an insulating coating that is formed on a surface of the conductor portion that faces in the slot depth direction is thinner than a thickness of a portion of the insulating coating that is formed on a surface of the conductor portion that faces in a direction of slot arrangement. | 09-03-2015 |
20150349611 | ROTARY ELECTRIC MACHINE - Insulators are respectively disposed such that longitudinal directions of trunk portions are oriented in a radial direction of teeth, and so as to place bottom surfaces of the trunk portions alongside two axial end surfaces of the teeth, concentrated winding coils are configured by winding conductor wires so as to be wound in multiple layers around the teeth so as to pass through a concave space that is formed by the trunk portions and first and second flange portions at two axial ends of the teeth, the second flange portion is disposed on an end surface of a core back of a stator core, and a temperature detecting element is installed by being inserted into an element insertion aperture that is formed on the second flange portion so as to be able to detect a temperature of a coil end of the concentrated winding coils. | 12-03-2015 |
Masayori Inoue, New Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20140011228 | Labeled Biomolecular Compositions and Methods for the Production and Uses Thereof - Disclosed herein is a set of | 01-09-2014 |
Michiaki Inoue, Cincinnati, OH US
Patent application number | Description | Published |
---|---|---|
20130210022 | METHOD OF IDENTIFYING AN AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES - A method to identify an agent for reducing an odor of a pyrazine derivative, comprising: | 08-15-2013 |
20130210775 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES - Provided is an agent for reducing odors of pyrazine derivatives based on an olfactory receptor antagonism. The agent for reducing odors of pyrazine derivatives includes at least one antagonist of olfactory receptor OR5K1 as an active ingredient. | 08-15-2013 |
20130280188 | SELF-TANNING COSMETIC - A self-tanning cosmetic comprising components (A), (B) and (C), and a self-tanning method reducing an odor derived from a compound represented by the following formula (1), comprising a step of application of the cosmetic to the skin for a browning reaction, wherein the cosmetic comprises: | 10-24-2013 |
20150110669 | Inhibitor of Odor Caused by Sotolone - It is intended to provide a substance inhibiting an odor caused by sotolone. The present invention provides an inhibitor of an odor caused by sotolone, comprising an antagonist of an olfactory receptor OR8D1 as an active ingredient. | 04-23-2015 |
20150110731 | Inhibitor of Odor Caused by Furaneol - Provided is a substance inhibiting an odor caused by 2,5-dimethyl-4-hydroxy-3(2H)-furanone. An inhibitor of an odor caused by 2,5-dimethyl-4-hydroxy-3(2H)-furanone, comprising a substance inhibiting the response of an olfactory receptor OR5K1 as an active ingredient. | 04-23-2015 |
20150111229 | Method for Searching for Inhibitor of Odor Cause By Furaneol - It is intended to identify a substance inhibiting an odor caused by 2,5-dimethyl-4-hydroxy-3(2H)-furanone. The present invention provides a method for searching for an inhibitor of an odor caused by 2,5-dimethyl-4-hydroxy-3(2H)-furanone, comprising: adding a test substance and 2,5-dimethyl-4-hydroxy-3(2H)-furanone to an olfactory receptor OR5K1 or a polypeptide having at least 80% amino acid sequence identity thereto; measuring the response of the olfactory receptor or the polypeptide to 2,5-dimethyl-4-hydroxy-3(2H)-furanone; and identifying a test substance inhibiting the response of the olfactory receptor or the polypeptide, on the basis of the measured response. | 04-23-2015 |
Nozomu Inoue, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20160093093 | Kinematic Analysis based on MRI Bone Marrow Signals - A method of a measuring kinematic parameter in a subject is provided. The method includes obtaining a first magnetic resonance (MR) image set of a bone marrow segment of the subject in a first position and obtaining a second MR image set of the bone marrow segment of the subject in a second position where the second position different from the first position. The method further includes registering the first image set with the second image set and measuring a kinematic parameter. | 03-31-2016 |
Riku Inoue, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20150228191 | Navigation Directions Specific to Device State - To provide effective navigation directions to a user in an automotive environment, a system determines information related to navigating the user to a destination, determines whether a screen of the portable device currently is in a line-of-sight with the user and generates a navigation instruction based on the determined information. Generating the navigation instruction includes selecting a level of detail of visual information for the navigation instruction in view of whether the screen is in the line-of-sight with the user. | 08-13-2015 |
Riku Inoue, Stanford, CA US
Patent application number | Description | Published |
---|---|---|
20090132385 | METHOD AND SYSTEM FOR MATCHING USER-GENERATED TEXT CONTENT - According to a computer implemented method and system for matching user-generated text content, users “freely” specify content by means of fed-in texts which are matched automatically, according to rules in the embodiment. An embodiment of the invention allows customers to specify what items or services to request or offer by adding, to the “MyHaves” or “MyWants” selection criteria, using typed-in descriptions. Traditionally, for the purpose of matching supplies and demands, the specification of an individual's “wants” and “haves” is done by selecting options that are predefined by, or hard-coded into, the system's “drop-down menu”—rather than allowing customers to freely define what they want or have. This method under consideration, however, provides an efficacious solution: customers are free to request an item or service by entering standard descriptive texts describing what s/he wants in a customizable manner very akin to the flexibility associated with verbal speech, with the assurance that these human-entered texts will be matched automatically. Similarly, a customer is free to offer an item or service in the aforementioned (text-descriptive) way. The entered texts are in the form of a specific human language (e.g. English, Chinese, etcetera) using the desired input device, such as a computer keyboard. The system algorithm of an implementation then “crawls” through the network of user generated texts (user-defined texts) to find matches between what people are offering and what others are requesting, while watching out for typographical errors (in the text content) made by customers. That is to say, the algorithm in the embodiment scours the texts in the “MyWants” section of requesters and sees if there are corresponding matches found in the “MyHaves” section of offerers, while paying attention to certain system rules. | 05-21-2009 |
Shinichiro Inoue, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20120185407 | CREATING AND MAINTAINING A PAYOUT-READY PORTFOLIO WITHIN AN INVESTMENT PLAN TO GENERATE A SUSTAINABLE INCOME STREAM - Financial advisory methods and systems for creating a steady lifetime income stream within an investment plan is provided. According to one embodiment, based on an investor's current holdings in the investment plan, a pattern of periodic cash payouts is identified that can be made to the investor from an in-plan payout program implemented with the limited universe of financial products available within the investment plan. The assets of the investment plan are rebalanced to form a payout portfolio and an equity exposure portfolio. The payout portfolio is constructed to create an annuity-like stream of income to support the pattern of periodic cash payouts and includes multiple bond funds. The equity exposure portfolio is constructed to address inflation risk by providing an ability to rise with equities markets. Finally, a periodic cash payout of the pattern of periodic cash payouts is caused to be paid to the investor from the investment plan. | 07-19-2012 |
20120185408 | CREATING AND MAINTAINING A PAYOUT-READY PORTFOLIO WITHIN AN INVESTMENT PLAN TO GENERATE A SUSTAINABLE INCOME STREAM - Financial advisory methods and systems for creating a steady lifetime income stream within an investment plan is provided. According to one embodiment, based on an investor's current holdings in the investment plan, a pattern of periodic cash payouts is identified that can be made to the investor from an in-plan payout program implemented with the limited universe of financial products available within the investment plan. The assets of the investment plan are rebalanced to form a payout portfolio and an equity exposure portfolio. The payout portfolio is constructed to create an annuity-like stream of income to support the pattern of periodic cash payouts and includes multiple bond funds. The equity exposure portfolio is constructed to address inflation risk by providing an ability to rise with equities markets. Finally, a periodic cash payout of the pattern of periodic cash payouts is caused to be paid to the investor from the investment plan. | 07-19-2012 |
20140249985 | CREATING AND MAINTAINING A PAYOUT-READY PORTFOLIO WITHIN AN INVESTMENT PLAN TO GENERATE A SUSTAINABLE INCOME STREAM - Financial advisory methods and systems for creating a steady lifetime income stream within an investment plan is provided. According to one embodiment, a feasible, personalized pattern of periodic cash payouts from an investment plan is structured to achieve level annual income during a payout period when combined with other income sources. A mapping is maintained of fixed income investments from a limited universe of financial products available within the investment plan to corresponding constant maturity Treasury bond (CMT) weights. Based on the mapping, a payout program is designed that is expected to generate a stream of income sufficient to fund the cash payouts by determining an appropriate allocation of assets within the investment plan among the fixed income investments. A payout portfolio is formed within the investment plan including holdings in the fixed income investments in accordance with the determined appropriate allocation. The cash payouts are paid to the investor. | 09-04-2014 |
Taeko Inoue, Pasadena, TX US
Patent application number | Description | Published |
---|---|---|
20140120081 | USE OF CARBON NANOMATERIALS WITH ANTIOXIDANT PROPERTIES TO TREAT OXIDATIVE STRESS - In some embodiments, the present invention provides methods of treating oxidative stress in a subject by administering a therapeutic composition to the subject. In some embodiments, the therapeutic composition comprises a carbon nanomaterial with anti-oxidant activity. In some embodiments, the anti-oxidant activity of the carbon nanomaterial corresponds to ORAC values between about 200 to about 15,000. In some embodiments, the administered carbon nanomaterials include at least one of single-walled nanotubes, double-walled nanotubes, triple-walled nanotubes, multi-walled nanotubes, ultra-short nanotubes, graphene, graphene nanoribbons, graphite, graphite oxide nanoribbons, carbon black, oxidized carbon black, hydrophilic carbon clusters, and combinations thereof. In some embodiments, the carbon nanomaterial is an ultra-short single-walled nanotube that is functionalized with a plurality of solubilizing groups. In some embodiments, the carbon nanomaterial is a polyethylene glycol functionalized hydrophilic carbon cluster (PEG-HCC). In some embodiments, the administered therapeutic compositions of the present invention may also include an active agent or targeting agent associated with the carbon nanomaterial. Additional embodiments of the present invention pertain to the aforementioned carbon nanomaterial compositions for treating oxidative stress. | 05-01-2014 |
Takayo Inoue, Malden, MA US
Patent application number | Description | Published |
---|---|---|
20080269340 | BIS (thio-hydrazide amide) salts for treatment of cancers - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 10-30-2008 |
20090281172 | BIS(THIO-HYDRAZIDE AMIDE) SALTS FOR TREATMENT OF CANCERS - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 11-12-2009 |
20100324143 | BIS(THIO-HYDRAZIDE AMIDE) SALTS FOR TREATMENT OF CANCERS - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 12-23-2010 |
20110059893 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 03-10-2011 |
20120035266 | BIS(THIO-HYDRAZIDE AMIDE) SALTS FOR TREATMENT OF CANCERS - Disclosed are bis(thio-hydrazide amide) disalts and pharmaceutical compositions thereof. Also disclosed are methods of using bis(thio-hydrazide amide) disalts to treat cancer. | 02-09-2012 |
20120289483 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 11-15-2012 |
20130109045 | METHODS OF IDENTIFYING HSP90 INHIBITORS WITH LESS OCULAR TOXICITY | 05-02-2013 |
20140045795 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 02-13-2014 |
20140127740 | METHODS OF IDENTIFYING HSP90 INHIBITORS WITH LESS OCULAR TOXICITY - Provided is a method of identifying Hsp90 inhibitors with substantially less ocular toxicity or with substantially improved ocular toxicity profile. The method comprises measuring the respective concentrations of an Hsp90 inhibitor in the retina and plasma at certain time points following the administration of the Hsp90 inhibitor in a subject, and determining the concentration ratio of the Hsp90 inhibitor between retina and plasma, where a certain ratio is indicative that the Hsp90 inhibitor has substantially less ocular toxicity. The method also includes identifying an Hsp90 inhibitor with substantially less ocular toxicity, or with a substantially improved ocular toxicity profile, by determining the elimination rate of the Hsp90 inhibitor from the retina following administration of the Hsp90 inhibitor, where a certain elimination rate is indicative that the Hsp90 inhibitor will induce substantially less ocular toxicity. | 05-08-2014 |
Takayo Inoue US
Patent application number | Description | Published |
---|---|---|
20100311840 | ORAL FORMULATIONS OF BIS(THIOHYDRAZIDE AMIDES) - Disclosed herein are oral formulations of bis(thio-hydrazide amides) compounds of the following structural formula (I): or a pharmaceutically acceptable salt thereof, wherein R | 12-09-2010 |
Tatsuya Inoue US
Patent application number | Description | Published |
---|---|---|
20120256533 | PHOSPHOR, METHOD FOR PRODUCING PHOSPHOR, PHOSPHOR-CONTAINING COMPOSITION, LIGHT-EMITTING DEVICE, LIGHTING SYSTEM AND IMAGE DISPLAY DEVICE - To provide a yellow to orange phosphor which has high luminance and excellent temperature characteristics and which also has high luminance when mixed with a phosphor of a different color. | 10-11-2012 |
Tomoko Inoue US
Patent application number | Description | Published |
---|---|---|
20150157064 | KIMONO - An object of the present invention is to provide a kimono | 06-11-2015 |
Tsuyoshi Inoue US
Patent application number | Description | Published |
---|---|---|
20110209994 | PROTECTIVE SHEET AND USE THEREOF - A protective sheet (for example, a protective sheet for masking during plating) is provided that has an excellent balance of adherence to the surface of an adherend and easy releasability when heat and pressure bonded. The protective sheet includes a substrate and a pressure-sensitive adhesive (PSA) layer which is provided on one side of the substrate. The PSA layer is thermoplastic. When the protective sheet is pressure bonded to a polyimide film at a temperature of 120° C. and a pressure of 0.34 MPa for a pressing time of 5 seconds, the protective sheet has a peel strength PS | 09-01-2011 |